$229.54-0.20 (-0.09%)
Molina Healthcare, Inc.
Molina Healthcare, Inc. in the Healthcare sector is trading at $229.54 with a market capitalization of $10.6B. Wall Street consensus targets $191.76 (17 analysts), implying a -16.5% move over the next 12 months. The stock is currently 26% below its 52-week high of $311.52, remaining 35.8% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $10.80Bβ | $11.38Bβ | $11.48Bβ | $11.43Bβ | $11.15B |
| Gross Profit | $1.02Bβ | $701.00Mβ | $927.00Mβ | $1.17Bβ | $1.28B |
| Operating Income | $176.00Mβ | -$162.00Mβ | $137.00Mβ | $373.00Mβ | $433.00M |
| Net Income | $14.00Mβ | -$160.00Mβ | $79.00Mβ | $255.00Mβ | $298.00M |
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Me...
Molina (MOH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.
When Wall Street turns bearish on a stock, itβs worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Joel Greenblatt's Magic Formula flags Peabody Energy, Molina Healthcare, and H&R Block as cheap businesses worth owning, but cheap and high-quality still fails retirement investors if the income dries up when markets turn ugly.
Molina Healthcare (MOH) has a clear path to earnings growth through 2027, supported by the reversal